Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-220.89	-5387.77	-1679.03
Graham Fair Price	-73.27	3.92	14.66
PEG	134094.00	0.11	< 0.005
Price/Book	-24.63	0.85	1.13
Price/Cash Flow	-11.71	-26.40	29.90
Prices/Earnings	-871.77	-10.08	-1.04
Price/Sales	31.78	3.19	2.42
Price/FCF	-11.71	-26.40	29.90
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.83	0.23	0.22
Operating Margin	86.80	-0.08	-0.61
ROA	92.22	< 0.005	-0.09
ROE	-0.27	-0.02	92.24
ROIC	-0.11	< 0.005	92.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.04	92.58
Dividends QOQ	1.02	-0.43	-57.24
EBIT QOQ	-112.52	0.93	-99.18
EPS QOQ	-127.80	0.93	-99.28
FCF QOQ	0.86	-1.83	113.66
Revenue QOQ	0.05	-0.44	811.39
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	82.81	150.13	81.30
Days Sales Outstanding (DSO)	152.08	202.90	33.42
Inventory Turnover	1.09	0.60	-44.84
Debt/Capitalization	0.56	0.57	1.19
Quick Ratio	0.95	0.79	-16.88
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.93	5.69	-4.01
Cash	1.86	1.60	-13.76
Capex	-0.10	-0.04	59.24
Free Cash Flow	0.22	-0.18	-18.06
Revenue	2.76	1.52	-45.10
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.28	1.30	1.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-773.59	-2969.69	-283.88
Naive Interpretation	Member

06 - Financial Health · Weak

Rating